Facility & Quality Roadmap
Our roadmap sets out where NexaPeptide stands today and where we are headed. Rather than reacting as issues arise, we follow a clear plan that keeps quality control, documentation and reliability moving forward — one step at a time.
Where we are going
- 2023
Founded
NexaPeptide was established to give European researchers a supplier they can trust — built from day one around purity, documentation and transparency, with laboratory partners evaluated against our quality standards.
- Now
Quality & documentation
Per-batch analytical documentation (HPLC and mass spectrometry) where available, clear research-only disclaimers on every product, a reconstitution calculator, and discreet EU-wide shipping with careful handling.
- Next
Expanded verification
Broadening batch documentation coverage across the catalog and strengthening independent-testing pathways, so more compounds ship with accessible identity and purity data.
- Ahead
Traceability & reach
Enhanced batch traceability, a wider verified catalog, and faster EU fulfilment — investing where it improves reliability for the research community we serve.
Why it matters
A clear roadmap keeps our priorities honest and measurable. It aligns sourcing, documentation and logistics around a single goal: dependable research-grade compounds, backed by transparent information. As the field and our catalog grow, this plan keeps every improvement pointed at reliability for the laboratories that depend on us.